Therefore, this project aims to evaluate the clinical efficacy and prognosis of CO2 fractional laser combined with compound betamethasone injections in treating vitiligo, elucidating their modulation of the inflammatory response via IL-17, IFN-γ, and IL-10, and their role in vitiligo treatment. This evidence concerns the gene IFNG and vitiligo.